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to study the availability of information about the studied popula-
tion, clinical experience, pharmacokinetic properties, and drug–drug 
interactions. Using the Systematic Information for Monitoring score, 
available information was considered clinically applicable if it pro-
vided information that could be applied in clinical practice. Missing 
information was either a statement that information was absent, 
unjustifiably nonavailable information, or hollow statements (eg, 
“caution in older patients”). Descriptive statistics (frequencies) were 
applied using SPSS 20.0.
Results: The availability of relevant and clinically applicable infor-
mation ranged between 10% (Belgian Repertorium and BNF) and 
20% (FK), except for the PL (mean, 66%). The PL, which is compa-
rable to the European SmPC, appeared a more extensive document 
(7–32 pages) than the other handbooks (2 pages). In the handbooks, 
most information was present about drug–drug interactions (range, 
30%–75%). Information about patient characteristics and about 
experience in older people was present in < 7% of the handbook 
texts, except for the PL (48% and 81%, respectively). Clinically 
applicable information (what to monitor, critical value, how to 
respond) concerning renal impairment ranged from 4% to 29%.
Conclusion: This study found that the availability and clinical appli-
cability of information about older people for rational prescribing of 
medicines is incomplete in the investigated European and American 
handbooks. Because these handbooks are the primary documents 
that guide prescribing in actual medical practice, the availability and 
clinical applicability of the information on older individuals should 
be improved.
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Introduction: The aim of this study was to investigate the effect of 
chronic pravastatin treatment on diminished corpus cavernosum 
(CC) function associated with aging.
Patients (or Materials) and Methods: Male rats were divided into 3 
groups as young rats (12–14 weeks old), aged rats (72–80 weeks old), 
and aged rats given 10 mg/kg/d of pravastatin in drinking water for 
6 weeks. Systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) were monitored by tail-cuff method. Total cholesterol, LDL-
cholesterol, HDL-cholesterol, triglycerides, and testosterone levels 
were estimated in blood. NO-mediated endothelium-dependent and 
neurogenic CC relaxation were evaluated by acetylcholine (ACh, 
0.1 nM–100 µM), and electrical field stimulation (EFS, 30 V, 5 ms, 
2–32 Hz), respectively. Changes in protein expression levels of eNOS, 
p-eNOS, and nNOS were assessed by immunohistochemistry.
Results: In aged rats, NO-mediated both endothelium-dependent 
and neurogenic CC relaxation was significantly impaired as com-
pared with young rats. Besides, eNOS and nNOS expressions 
decreased significantly in CC from aged rats compared with those 
from young rats. The diminished relaxation in response to ACh or 
EFS as well as reduced expressions of eNOS, p-eNOS and nNOS 
in CC of aged rats were improved by pravastatin treatment. SBP, 
DBP, and plasma levels of total cholesterol, LDL-cholesterol, HDL-
cholesterol, triglycerides, and testosterone did not change with aging 
or pravastatin treatment.
Conclusion: The present results suggest that chronic pravastatin 
treatment enhances NOS activity and NO-mediated relaxations in 
the rat CC, and this effect does not seem to be associated with lipid-
lowering effect of this drug.
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Introduction: Adverse drug reactions (ADR) in children are an 
important medical problem. The ADRs in pediatrics are not the same 
in adults. Our aim was to define such specifity for periods of child-
hood and to compare found results with ones of adults.
Patients (or Materials) and Methods: ARCADe (Adverse Reactions 
in Crimea Autonomy DatabasE) was used for search of ADRs and 
their analysis. Classification of age stages of American Academy 
of Pediatrics was used. It defines babies (0–1 y.o.), toddlers (1–3), 
preschool (3–5), and grade-school (5–12) periods of childhood, 
and teenagers (12–18). The pharmaceutical groups and drugs were 
determined using WHO ATC index. WHO classes and Naranjo 
algorithm was used in causality and FDA criteria in seriousness 
assessment.
Results: The total amount of ARCADe records in 2011–2012 
period is 2528. Amount of ADR reports for pediatric groups: 
babies, 187 (7.4%); toddlers, 138 (5.5%); preschool, 52 (2%); 
grade-school, 100 (4%); and teenagers, 52 (2%). Other reports 
were about reactions in adult patients (n = 1999, 79%). The 
amount of reports informing about ADR in male decreases with 
age. In babies, toddlers, and preschool children, ADRs in males are 
more often (55%–60%); in schoolchildren and teenagers, the ratio 
for males and females is 1:1, in adults ADRs in females are more 
frequent (60%). The most frequent clinical presentation of ADR 
in all groups is skin rash with different severity (including Lyell’s 
syndrome). In babies, rashes were found in 89.3% of cases; in tod-
dlers, in 77.5%; in preschool and grade-school children, in 75% 
and in 56%; and in teenagers, in 63.5% In adults, the frequency of 
rashes was lower (42%). The incidence of fever varied from 3.2% 
in babies to 11.4% in preschool children; then in teenagers and 
adults it decreases to 3.8% to 4%. The seriousness of ADRs was 
maximal in toddlers (75%), less in babies (71.7%); in other groups 
it was equal to adult rates (66%). The products caused ADRs most 
frequently in pediatric groups as well as in adults were antibacterial 
drugs. For them there was trend to decrease from babies (56.1%) 
to adults (36.7%) while in teenagers and adult patients the leader 
drug from this group was ceftriaxone (13.5% and 4.7%); in babies 
and toddlers ADR was mostly caused by ceftazidime (21.9% and 
12.3%). In preschool children, the leader was ibuprofen (7.7%) 
